GAM
PGNX

Gemmer Asset Management’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Gemmer Asset Management’s Portfolio PGNX Stock Details PGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-247
Closed -$1K – 1495
2019
Q4 		$1K Hold
247
– – ﹤0.01% 1327
2019
Q3 		$1K Buy
+247
New +$1.23K ﹤0.01% 1362
2018
Q4 		– Sell
-150
Closed -$1K – 1483
2018
Q3 		$1K Buy
150
+16
+12% +$123 ﹤0.01% 1371
2018
Q2 		$1K Buy
134
+17
+15% +$130 ﹤0.01% 1380
2018
Q1 		$1K Buy
+117
New +$778 ﹤0.01% 1400

Other funds holding PGNX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Gemmer Asset Management's PGNX Position: Q1 2020 in Review

Gemmer Asset Management sold out of Progenics Pharmaceuticals Inc (PGNX) in Q1 2020, closing a stake of 247 shares — an estimated $1K sold.

Gemmer Asset Management first reported a position in PGNX in Q1 2018 and held it in 5 quarters. The position peaked at $1K in Q4 2019. 129 funds tracked by Wall St. Rank hold PGNX as of Q1 2020.

  • Gemmer Asset Management reported no remaining Progenics Pharmaceuticals Inc position as of Q1 2020 after selling out during the quarter.
  • Gemmer Asset Management sold 247 Progenics Pharmaceuticals Inc shares in Q1 2020, an estimated $1K.
  • Gemmer Asset Management first reported a position in Progenics Pharmaceuticals Inc in Q1 2018 and held it in 5 quarters.
  • Gemmer Asset Management's Progenics Pharmaceuticals Inc position peaked at $1K in Q4 2019.
  • 129 funds tracked by Wall St. Rank held Progenics Pharmaceuticals Inc as of Q1 2020.

Based on Gemmer Asset Management's 13F filing for Q1 2020, filed 1 May 2020.